Prevalence of Monogenic Bone Disorders in a Dutch Cohort of Atypical Femur Fracture Patients

Wei Zhou1, Jeroen Gj van Rooij1, Denise M van de Laarschot1

  • 1Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.

Insights

Atypical femur fractures (AFFs) are linked to monogenic bone disorders, especially in patients showing symptoms. Genetic testing revealed pathogenic variants in 15% of AFF patients, highlighting the need for clinical evaluation.

Area of Science:

  • Genetics
  • Orthopedics
  • Endocrinology

Background:

  • Atypical femur fractures (AFFs) are rare but associated with bisphosphonate use.
  • AFFs have also been observed in patients with monogenic bone disorders, independent of bisphosphonate treatment.
  • The precise link between AFFs and monogenic bone disorders remains unclear.

Purpose of the Study:

  • To investigate the prevalence of monogenic bone disorders in a cohort of Dutch patients diagnosed with AFFs.
  • To identify genetic underpinnings contributing to AFFs in this cohort.

Main Methods:

  • Recruitment of AFF patients from two Dutch specialist bone centers.
  • Review of medical records for clinical indicators of monogenic bone disorders.
  • Whole-exome sequencing of 37 candidate genes and analysis of copy number variations.
  • Classification of genetic variants using ACMG guidelines.

Main Results:

  • The cohort included 60 AFF patients; 95% had used bisphosphonates.
  • Fifteen percent (15%) of AFF patients exhibited clinical features suggestive of monogenic bone disorders.
  • Eight patients (54% of those with clinical suspicion) carried pathogenic variants in genes like PLS3, COL1A2, LRP5, or ALPL.
  • Overall, 15% of the AFF cohort had a pathogenic variant, including one with a TENT5A deletion.

Conclusions:

  • A significant association exists between AFFs and monogenic bone disorders, particularly osteogenesis imperfecta and hypophosphatasia, especially in symptomatic individuals.
  • Genetic testing in AFF patients with clinical suspicion yields a high rate of pathogenic variants, underscoring the importance of thorough clinical assessment.
  • While bisphosphonate use's role is uncertain, these findings are crucial for managing patients with AFFs.